Silvy is a seasoned executive, with extremely valuable experience in scaling a science-driven start-up, and an experienced scientist as well. From the 1st of May on, she will employ those skills to grow RiboPro in the function of Chief Operating Officer (COO). At RiboPro, we all look forward to working together with her to elevate our service to new heights and build a sustainable business. We are confident she will bring us a major step closer to our ambition of having helped researchers make 10,000 scientific discoveries and create 1000 new potential treatments by 2030.
Our new COO: Silvy van Tuijl
Biotech Scale-up RiboPro Announces Funding Round To Support Preclinical Development and International Expansion
Ardena and RiboPro Forge Strategic Alliance to Support the RNA Revolution with End-to-End Manufacturing of Advanced mRNA and LNP Solutions
RIBOPRO joins the Wellcome Leap Health Breakthrough Network